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Background: Currently there is no disease-specific outcome measure to assess the health-related quality of life
(HRQOL) of pediatric patients with Eosinophilic Esophagitis (EoE). Therefore, the objective of this qualitative study
was to further develop and finalize the items and support the content validity for the new Pediatric Quality of Life
Inventory™ (PedsQL™) Eosinophilic Esophagitis Module.
Methods: Multiphase qualitative methodology was utilized in the development of the PedsQL™ EoE Module
conceptual model. Focus interview transcripts of pediatric patients with EoE and their parents and expert review
were previously used to develop the initial items and domains for the PedsQL™ EoE Module. In the current
investigation, utilizing the respondent debriefing methodology, cognitive interviewing was conducted individually
with pediatric patients with EoE and their parents on each newly developed item.
Results: Information from a total of 86 participants was obtained in combination from the previous investigation
and the current study. From the previous 42 focus interviews, items were developed around the domain themes of
symptoms, difficulties with eating food, treatment adherence, worry about symptoms and illness, feelings of being
different than family and peers, and problems discussing EoE with others. In the current study’s cognitive
interviewing phase, a separate cohort of 44 participants systematically reviewed and provided feedback on each
item. Items were added, modified or deleted based on this feedback. Items were finalized after this feedback from
patients and parents.
Conclusions: Using well-established qualitative methods, the content validity of the new PedsQL™ Eosinophilic
Esophagitis Module items was supported in the current investigation. In the next iterative instrument development
phase, the PedsQL™ Eosinophilic Esophagitis Module is now undergoing multisite national field testing.
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Eosinophilic esophagitis (EoE) is a chronic esophageal in-
flammatory condition with a prevalence that continues to
increase [1]. Food allergies are a common cause of EoE,
and therefore food restriction is a common treatment [1].
Although patients experience significant disease- and
treatment-related sequelae, there is no validated EoE-
specific health-related quality of life (HRQOL) instrument* Correspondence: jfrancio@NEMOURS.org
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reproduction in any medium, provided the orto document the impact of EoE on the daily lives of
affected pediatric patients. Additionally, current clinical
practice in EoE pays little attention to patient HRQOL, in-
stead focusing primarily on histologic and symptomatic
improvement outcomes [1].
In order to partly address this significant gap in the
empirical literature, we recently utilized the Pediatric
Quality of Life Inventory™ (PedsQL™) 4.0 Generic Core
Scales to investigate the generic HRQOL of patients with
eosinophilic gastrointestinal (GI) disease (EGID, includ-
ing EoE) in comparison with several other pediatric
chronic conditions and healthy controls [2]. Not onlyal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cantly lower generic HRQOL than healthy controls, but
they reported generic HRQOL lower than pediatric
patients with inflammatory bowel disease, epilepsy, type
1 diabetes, sickle cell disease, post-renal transplantation,
cystic fibrosis, and obesity [2].
Although the PedsQL™ 4.0 Generic Core Scales assess
generic issues common across healthy and ill pediatric
populations [3], a disease-specific HRQOL instrument is
essential to understanding the particular health issues
most germane to pediatric EoE patients from their per-
spective. In addition, an EoE disease-specific HRQOL in-
strument would be expected to be more sensitive to
detecting change in health status over time within a
population of EoE children than a generic scale. To bet-
ter understand differences in health status within the
population of pediatric EoE patients and to enhance the
ability to measure the impact of disease-modifying ther-
apies, we previously conducted individual focus inter-
views of pediatric patients with EoE and parents and
solicited medical expert review in the development of
the conceptual model and the initial items for a new
multidimensional disease-specific HRQOL instrument
targeted to pediatric EoE [4]. In the current study, we
further utilize qualitative methods, specifically cognitive
interviewing techniques, to support content validity and
to finalize the items for a quantitative analysis subse-
quent to field testing.
The FDA patient-reported outcome (PRO) guidance for
industry defines content validity as evidence demonstrat-
ing that an instrument measures “the concept of interest,
including evidence that the items and domains of an in-
strument are appropriate and comprehensive relative to
its intended measurement concept, population, and use”
[5]. Furthermore, the FDA has emphasized the critical
value of patient input in supporting content validity, not-
ing that “documentation of patient input in item gener-
ation as well as evaluation of patient understanding
through cognitive interviewing can contribute to evidence
of content validity” [5]. Qualitative methods, in particular
focus groups/individual interviews and cognitive inter-
viewing techniques, have emerged as the standard meth-
odology for supporting the content validity for new or
existing PRO instruments [6-10] and have served as the
foundation for previous PedsQL™ Disease-Specific Mod-
ules [11-18]. These qualitative methods are consistent with
recent FDA guidelines on PRO measures, and as such help
establish the content validity of newly developed disease-
specific HRQOL items [5]. These iterative steps include: a
comprehensive review of the literature, expert opinion,
and the patient perspective derived from focus
groups/individual interviews (used to develop the
conceptual model for relevant disease-specific domains),
item generation guided by the conceptual model, and theiterative process of revising the items and item content
based on patient cognitive interviewing techniques [6-10].
Previously, Flood and colleagues contributed significantly
to EoE PRO development by utilizing expert opinion and
cognitive interviews to generate a pediatric EoE symptom
metric (the Symptom Questionnaire for Eosinophilic
Esophagitis) for use by patients aged 8 – 17 and caregivers
of patients aged 2 – 7 [19]. However, this measure was lim-
ited by age range and methods of item generation.
Given the lack of an empirically-validated multidimen-
sional pediatric EoE disease-specific HRQOL instrument
in the extant literature for patient self-report for ages 5–
18 years and parent proxy-report for ages 2–18 years,
the objective of the present study was to address this
gap in the empirical literature and to describe the quali-
tative methods, specifically cognitive interviewing tech-
niques, utilized in the further item development and
content validation phase for generating the final items
for the new PedsQL™ Eosinophilic Esophagitis Module
for pediatric patients with EoE.
Methods
All research for this study was performed in compliance
with both the Declaration of Helsinki (http://www.wma.
net/e/policy/b3.htm) and Cincinnati Children’s Hospital
Medical Center (CCHMC) ethical guidelines for clinical
research, in addition to being approved by the CCHMC
Institutional Review Board. Parental permission
(informed consent) was obtained from all caregivers and
assent from children aged 8 – 17. Informed consent was
obtained from patients aged 18.
The validated PedsQL™ module development guide-
lines, the consolidated criteria for reporting qualitative
research (COREQ), and the FDA guidelines on PRO de-
velopment were used to develop the methodology for
item development and content validity [5,16,17,20]. De-
velopment of the initial items for the PedsQL™ EoE
Module began in 2008.
Research team
The research team in this study was comprised of five
healthcare experts in the fields of Allergy and Gastro-
enterology with a combined experience of over 30 years
researching and treating EoE and two psychologists with
expertise in PRO development and methodology (includ-
ing the developer [J.W.V.] of the PedsQL™). While inter-
viewers were specifically trained in qualitative methodology,
all members of the research team developed the interview
guidelines and reviewed the transcriptions of the audio-
taped interviews.
Study population
Pediatric patients with EoE 5 to 18 years of age and par-
ents of children with EoE 2 to 18 years of age were
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orders clinic in Cincinnati, Ohio. In the initial qualitative
phases of the PedsQL™ EoE Module item development, it
was vital to assess EoE-specific concerns and not those
related to other co-morbidities. Pediatric participants were
restricted to those with a confirmed diagnosis of EoE and
without other co-morbidities, including: inflammatory
bowel disease, celiac disease, psychiatric disorder, and/or
therapy with psychiatric/behavioral medication. Purposive
sampling was utilized to ensure that the full clinical
spectrum of pediatric EoE phenotypes, ages and symptom-
atology was represented. Participants were given $45 in
gift cards for participating.
Focus interviews
Draft PedsQL™ EoE Module items were developed from
42 transcripts of 18 child and 24 parent individual focus
interviews. Details of the individual focus (concept elicit-
ation) interviews have been described previously [4].
Transcriptions of audio-recorded interview sessions
were analyzed by the research team, and participant
responses were grouped according to age and subject.
Patient and parent responses were separated. The re-
search team reviewed these data to develop domains and
initial item content by consensus, with all disagreements
resolved after further discussion.
Expert opinion
Items that emerged from the individual focus interviews
were integrated into an initial draft of the PedsQL™ EoETable 1 Cognitive interview respondent debriefing
Subject Question
Directions How would you make the
What does "in the past mo
When you see "the past m
Items In your own words, what d
What does this question m
Was this question easy to u
How would you change th
Was this item hard to answ
How did you choose your
Domains In your own words, what d
How do you think these it
Are there any questions th
Response Choices What do you think about t
How would you make the
Overall Assessment Are there things that we fo
Overall thoughts/opinions
Anything you would changModule [4]. Local (authors) and national (listed in
acknowledgements) EoE experts in the fields of Allergy,
Gastroenterology, and Psychology then reviewed this
draft. To ensure that the focus of the PedsQL™ EoE
Module reflected patient and parent perspectives, these
clinical experts were allowed to suggest new items, but
no items were deleted from the list generated by the pa-
tient and parent focus interviews. Several clinical experts
suggested adding a number of different questions to ad-
dress dysphagia, because many patients have adapted to
their disease and do not necessarily realize they are hav-
ing trouble swallowing. Therefore, a question regarding
having to drink more liquids when swallowing foods was
added to the draft item pool to be reviewed by patients
and parents during the cognitive interviewing phase of
the study.
Operationalizing items
The recall period and the Likert-type response scale for
the PedsQL™ EoE Module match those of the generic
and disease-specific PedsQL™ instruments, which have
previously undergone extensive testing [3,11-18]. Items
generated by individual focus interview participants and
national experts were used to create a draft PedsQL™
EoE Module, utilizing a protocol from the existing meth-
odological literature [21]. The reading level, grammar,
and syntax of the PedsQL™ EoE Module items were
designed to be structurally equivalent to those in exist-
ing PedsQL™ instruments [3,11-18].directions more clear/easy to understand?
nth" mean to you?
onth", what days did you include?
o you think this question is asking?
ean to you? What did you think of when answering this question?
nderstand? Are there any specific words that are difficult to understand?
e words to make it more clear?
er? If yes, why?
answer?
o you think this group of questions is asking about?
ems are related?
at do not belong in this group?
he response choices?
response choices clearer or easier to understand?
rgot to ask about that you think are important?
of the questionnaire?
e in the questionnaire as a whole?
PedsQL™ EoE Module draft developed from 42 Focus 
Interviews
Research team reviewed responses from 44 Cognitive 
Interviews
Cognitive Interviews: Parent 
27 new participants  
Ages 2-4, 5-7, 8-12, 13-18 
Cognitive Interviews: Child 
17 new participants 
Ages 5-7, 8-12, 13-18 
PedsQL™ EoE Module content validated
Figure 1 Focus and Cognitive Interviewing Flowchart. Focus
interview transcripts of pediatric patients with EoE and their parents
were used to develop the items and domains for the PedsQL™ EoE
Module [4]. Cognitive interviewing was conducted in the current
study with separate cohorts of pediatric patients and their parents in
the 5–7, 8–12 and 13–18 year old age groups, while parent proxy-
reports were also obtained in the 2–4 year old age group.
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In the cognitive interviewing phase for the current study,
the updated draft PedsQL™ EoE Module was reviewed by
a unique cohort of 17 children with EoE and 27 parents of
children with EoE who were not participants in the previ-
ous focus interviews [4]. Both cohort groups were divided
among the patient age ranges of 2 – 4, 5 – 7, 8 – 12, and
13 – 18 years of age, consistent with previous PedsQL™
age groupings. Participants completed the draft PedsQL™
EoE Module instrument and then provided feedback
employing the previously described respondent debriefing
methodology (see Table 1) [16,17,21]. The goal of the cog-
nitive interviews was to obtain patient perspectives on the
meaning and clarity of all aspects of the questionnaire, in-
cluding: the instructions, domains, questions, and corre-
sponding answer choices. Participants also provided
feedback on the overall rationale and disease-relevance of
the PedsQL™ EoE Module draft. From these interviews
transcribed audiotapes and interviewer notes were used to
generate an item-by-item summary of each questionnaire
section and included recommendations for item modifica-
tions. Utilizing the same methodology as described for the
focus interviews [4,21], the PedsQL™ EoE Module items
and content were revised. The Flesch Reading Easiness
and Flesch-Kincaid Grade Level scores were utilized to
further evaluate the reading level and revise item structure
as needed. A summary of the content validation method-
ology using cognitive interviewing is provided in Figure 1.
Results
PedsQL™ EoE Module item development: previous focus
interviews findings
Basic allergic disease comorbidity and treatment demo-
graphics are summarized in Table 2 for this sample of par-
ticipants in the cognitive interviewing phase. Themes that
emerged from the individual focus interview transcripts
included symptoms, difficulties with eating, treatment ad-
herence, and discussing EoE with others, as well as worry
about the illness and feelings of being different than family
and peers [4]. Children with EoE and their parents
expressed concern about patients not being able to eat
what both their peers and other family members could
eat. Pediatric EoE patients often had concerns about
trouble swallowing, pain in the chest or abdomen, nausea
or vomiting, or difficulties eating. Children described dys-
phagia in varied ways, including trouble swallowing and
avoiding particular foods because of fears these foods
would get stuck in the esophagus while eating.
Many participants noted that they felt different than
their peers, often due to EoE not allowing them to partici-
pate fully in social activities centered on food. In addition,
the complicated treatment regimens and/or feeding tubes
common amongst EoE patients were a burden to them.
The subject of communication garnered a wide range ofresponses as well, including concerns regarding not only
health concerns with EoE, but with explaining the disease
itself to family, friends, or care providers. The EoE-specific
HRQOL domains were distinct from the generic PedsQL™
domains, and included: symptoms, treatment, activities
and school, worry, communication, and food and eating.
We discovered that patients and parents often had differ-
ent concerns, illustrating unique but complementary
aspects of EoE-specific HRQOL [4].
PedsQL™ EoE Module item development: cognitive
interviewing findings
Basic cohort demographic, age categories, allergic disease
comorbidity, medication use and EoE treatments are sum-
marized in Table 2. Selected respondent debriefing results
are summarized in Table 3. Most participants thought that
the PedsQL™ EoE Module items addressed their EoE-
specific HRQOL concerns. Domain-specific patient and
parent feedback are presented below.
Symptoms domain
In the EoE symptom domain, questions concerning dyspha-
gia were asked in several different ways: trouble swallowing,
feeling like food gets stuck while eating, needing to drink to
help swallow food, and taking a long time to eat. All of these
items were felt to be important to participants and were not
recognized as redundant. The order of the items was modi-
fied per respondent suggestions. A question regarding
weight loss and poor growth was felt to be too difficult to
answer in the 1 month timeframe and was therefore deleted.
Table 2 Demographics and general information for cognitive interview participants
Basic Demographics, Medical History, & Therapy Among 27 Total EoE patients
Male 19 (70.4%)
Caucasian 21 (77.8%)
Food Allergies 21 (77.8%)
Asthma 10 (37%)
Eczema 10 (37%)
Allergic Rhinitis 18 (66.7%)
Swallowed Steroid Therapy for EoE 12 (44.4%)
Proton Pump Inhibitor (PPI) Therapy for EoE 15 (55.5%)
Elimination Diet Therapy for EoE 21 (77.8%)
Elemental Diet Therapy for EoE 2 (7.4%)
Child & Teen Interviews Among 17 Total Child & Teen Interviews
Children 5–7 years old 5 (29.4%)
Children 8–12 years old 6 (35.3%)
Children 13–18 years old 6 (35.3%)
Parent Proxy Interviews Among 27 Total Parent Proxy Interviews
Parent Proxy Children 2–4 year old children 8 (29.6%)
Parent Proxy Children 5–7 year old children 7 (25.9%)
Parent Proxy Children 8–12 years old children 6 (22.2%)
Parent Proxy Children 13–18 year old teens 6 (22.2%)
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Overall this domain was well received by children, teens,
and parents. Unlike dietary interventions, respondents
expressed clear differences between difficulties with
medication adherence and difficulties with taking medi-
cations. This item was modified to two separate items
that were felt to better capture the intention of these
questions: “It is hard for me to remember to take my
medicines” and “I do not want to take my medicines.”
Adherence and difficulties with nasogastric or gastros-
tomy feeding therapy were also described as important
concerns but were included as conditional questions, be-
cause they relate only to children and teens using these
therapies. Adherence was not felt to be an important
issue for children ages 2 – 4 and 5 – 7, therefore adher-
ence items were not included for these age groups. In
the first PedsQL™ EoE Module draft, difficulties with
going to the doctor or hospital were described in a single
question. Many patients and their parents described
clear differences between going to the doctor, undergo-
ing an endoscopic procedure, and receiving allergy test-
ing. The revised module described these concerns as
three separate items.
Activities and school domain
The initial PedsQL™ EoE Module draft included an ac-
tivities and school domain. Many respondents did not
see how this domain differed from a similar domaincontained in the PedsQL™ 4.0 Generic Core Scales
(School Functioning Scale) and did not feel that these
repetitive items contributed to an EoE disease-specific
module intended to be co-administered with the generic
PedsQL™ instrument. Therefore, this domain was
deleted from the final draft of the PedsQL™ EoE Module
instrument.
Communication domain
Communication to parents, friends, other adults, and
health care providers about both EoE itself and how chil-
dren and teens suffering from it are feeling were felt to
be important disease-specific concerns. Children, teen,
and parent proxy-respondents suggested substituting the
word “explaining” with “telling.” In addition, a question
was included regarding telling important people with
whom children and teens spend a significant amount of
time communicating and interacting, such as teachers
and coaches, how they feel.
Food and eating domain
Overall, the items generated regarding food and eating
were felt to be significant EoE disease-specific outcomes
that reflect important concerns for EoE patients and
their parents. However, many patients are not treated
with dietary restriction, but instead with only swallowed
corticosteroids. Children, teens, and parents who were
not restricting foods identified this concern, and
Table 3 PedsQL™ EoE module respondent debriefing results
General changes
The activities and school domain in the first draft PedsQL™ EoE Module were felt to be redundant to the
domains in the PedsQL™ 4.0 Generic Core Scales.
****Symptoms domain****
Some participants felt that questions were not ordered correctly, forcing them to move back and forth between
questions. Question order was changed to reflect these suggestions, resulting in greater clarity. Order of
symptoms was changed.
Initial item Participant comments Revised item
I have stomachaches or
bellyaches
Although grammatically incorrect, “stomach aches”
or “belly aches” was easier for children to understand.
I have stomach aches or belly aches
I don’t grow as much as
other kids my age
5 children and many parents suggested removing.
A 30-day time frame is not adequate to determine
poor growth.
Deleted
****Treatment domain****
Initial item Participant comments Revised item
It is hard for me to take
my medicines
5 children felt this question was confusing. Language was changed to
determine adherence and emotional functioning in relation to
treatment, which tested well.
I do not want to take my medicines
I don’t like going to the doctor
or hospital
1 child and 5 parents agreed that degree and type of stress varied
between types of visits (i.e. a doctor visit, endoscopy, or allergy testing).
The group agreed that separating this question into three separate
questions would address this difference.
I do not like going to the doctor
I do not like getting an endoscopy
(scope, EGD)
I do not like getting allergy testing
****Communication domain****
Initial item Participant comments Revised item
Several parents wanted to include other adults like teachers, coaches,
family members, and babysitters, with whom many children spend
much of their time.
I have trouble talking to other adults
about how I feel
I have trouble explaining
EoE to other people
Many children misunderstood the word “explaining,” so it was changed
to “telling.” Parents found their children often do not explain EoE but
do tell peers about EoE.
I have trouble telling other people about
EoE
****Food & eating domain****
Concern was raised regarding participants not restricting foods as therapy for EoE, and therefore qualifier
question was added, indicating section should be completed only if allergic to foods
Initial item Participant comments Revised item
I eat things I’m not allowed to
eat
Several children and parents suggested “sneaking” or “cheating.” This
was reviewed with the other cognitive interview respondents who,
along with the group, agreed sneaking was a better word. Changed to
“allergic” foods to clearly refer to EoE-specific foods, not sugar/sweets.
It is hard for me not to sneak foods
that I am allergic to
I don’t want to sit at the table
to eat with my family and
friends
2 respondents felt that this question was not needed and was not
different than other questions in the food and eating domain.
Deleted
****Feelings/worry domain****
Initial item Participant comments Revised item
I worry about eating a
food I’m not supposed to
eat
4 children thought that referencing allergic foods was easier to
understand. Also, parents suggested feelings of being “mad” or “sad”
were articulated as concerns that would not be reflected in just “worry.”
I worry about eating foods I’m allergic to
or not supposed to eat
I feel mad (get upset) about not eating
foods I am allergic to or not supposed to
eat
I feel sad about not eating foods I am
allergic to or not supposed to eat
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based on whether dietary restriction was used as a ther-
apy for EoE. Patients without dietary restrictions and
their parents are now asked to leave this domain blank.
Respondents also expressed difficulty distinguishing the
difference between problems following the diet versus
problems adhering to the diet. Problems following the
diet was captured in the module draft with the two items
“It is hard not being allowed to eat some foods” and “I
wish I could eat certain things, but can’t,” and the latter
question was removed because many children found the
two items similar. Questions regarding difficulty not eat-
ing the same foods as friends and family were agreed to
be separate concerns and clear from the initial instru-
ment draft.
Worry/feelings domain
Emotional concerns with EoE disease and therapy were
nearly universally felt to be important components of
disease-specific items. In addition to feelings of worry
concerning eating foods, emotions such as “mad” or
“sad” were also expressed by families as important
aspects to be included. Because these were conditional
items (affecting only those with dietary restrictions), this
modification was addressed in the revised instrument.
Final data analysis and construction of the PedsQL™ EoE
Module final items
The research team revised items of concern to two or
more participants and reached a consensus on all items.
In addition, the Flesch Reading Ease and Flesch-Kincaid
Grade Level metrics were utilized to modify item lan-
guage, thereby increasing reading ease, decreasing grade
level, and allowing items to be more easily understood
by patients and parents. Items were finalized at this
stage once content saturation was achieved (no further
changes recommended by either the patients or their
parents) based on the cognitive interviewing findings.
Discussion
The PedsQL™ EoE Module is the first and only content-
validated pediatric patient self-report for ages 5–18 years
and parent proxy-report for ages 2–18 years multidi-
mensional HRQOL measurement instrument specific to
EoE, and consequently addresses an important gap in
the current empirical literature for this pediatric chronic
disease.
Pediatric patients and their parents felt that the EoE-
specific domains of symptoms, treatment, worry, com-
munication, food and eating, and feelings better
expressed the salient HRQOL concerns of families than
the PedsQL™ 4.0 Generic Core Scales alone. The
domains of food and worry were frequently identified by
patients and families as key components of EoE-specificHRQOL. The use of separate cohorts for the focus inter-
views and cognitive interviewing phases allowed further
elucidation of pediatric patient self-reported and parent
proxy-reported opinions and concerns, resulting in con-
tent saturation. The cognitive interviews were particu-
larly helpful in clarifying the directions and modifying
the items to allow for reading ease by using patient-
centered vocabulary. Utilizing the cognitive debriefing
methodology in the current study, the semi-structured
question format allowed patients and families the oppor-
tunity to explain in their own words the impact of EoE
on their family and to achieve content saturation prior
to finalizing the items.
Although being an important stride forward in the
field of pediatric EoE, this study is limited by a few con-
cerns, in particular when applying these results to non-
Caucasians and those with co-morbidities. To address
these potential limitations, we will next test the
PedsQL™ EoE Module items in a large national multisite
field test of patients and parents with a wide variety of
demographics and comorbidities. Finally, we will then
utilize quantitative methods to evaluate the reliability,
validity, and responsiveness of the PedsQL™ EoE Mod-
ule, allowing assessment of the potential performance of
the PedsQL™ EoE Module in clinical trials.
Conclusions
It is of critical importance to include patient self-
reported and parent proxy-reported outcomes when
evaluating pediatric EoE treatments. Our work both
demonstrates and emphasizes the significant impact of
EoE on overall health and well-being, rather than just a
focus on specific gastrointestinal symptoms, and is an
important consideration for future pediatric clinical
trials of new medications for pediatric EoE. The
PedsQL™ EoE Module will not only address critical gaps
in the literature and clinical practice, but also will pro-
vide pediatric patients and their families a voice to ex-
press the impact of EoE on their daily lives.
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